Zepbound (tirzepatide) has been FDA-approved since November 2023 and is the most effective weight-loss drug you can actually fill at a pharmacy
While current research focuses predominantly on hepatocytes, potential Kupffer cell modulation in NASH-related inflammation and fibrosis warrants further investigation (78)
When prescribed by a knowledgeable healthcare provider and used appropriately, peptide therapy is considered safe
Taken together, these results have demonstrated that BPC-157 induces proliferation, migration, and tube formation of endothelial cells, wherein the ERK1/2 signaling pathway plays a promoting role
Relationship between gastric emptying and diurnal glycemic control in type 1 diabetes mellitus: a randomized trial
Why it was included in the FDA ban Compounded Epitalon was banned because of a potential for peptide impurities and immune reactions